Cite
HARVARD Citation
Cascinu, S. et al. (2021). Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer – A GISCAD phase II randomized trial. European journal of cancer. pp. 422-429. [Online].